Anyone with a variant of uncertain significance on HRT for those with hypothyroidism or Hashimoto's

Understanding VUS in the Context of HRT and Thyroid Conditions

As the founder of CFP Weight Loss, I've worked with hundreds of women aged 45-54 who carry a variant of uncertain significance (VUS) while exploring hormone replacement therapy (HRT) for hypothyroidism or Hashimoto's thyroiditis. A VUS is a genetic change whose impact on health isn't fully clear yet. In thyroid patients, these often appear in genes related to hormone metabolism or autoimmune regulation. The good news? A VUS rarely means you must avoid HRT entirely. Instead, it calls for personalized monitoring rather than blanket restrictions.

Many in this age group face surging symptoms: stubborn weight gain around the middle, joint pain that makes movement difficult, and blood sugar swings that complicate diabetes management. These stem from declining estrogen, progesterone fluctuations, and poorly optimized thyroid levels. In my book, The CFP Method, I emphasize testing free T3, free T4, reverse T3, and thyroid antibodies before starting any HRT protocol.

Is HRT Safe with Hypothyroidism or Hashimoto's?

Clinical data shows most women with treated hypothyroidism tolerate bioidentical HRT well once their TSH stabilizes between 0.5-2.0 mIU/L. For Hashimoto's patients, the key is reducing inflammation first. I recommend starting with 25-50 mcg of levothyroxine or a desiccated thyroid blend while adding 5-10 mcg of liothyronine (T3) if conversion is poor. Once stable for 6-8 weeks, low-dose transdermal estradiol (0.025-0.05 mg patch) paired with oral micronized progesterone (100 mg nightly) often improves energy, joint comfort, and even insulin sensitivity.

Avoid oral estrogens if you have elevated blood pressure or clotting risks, common in this demographic. Transdermal delivery bypasses the liver and minimizes those concerns. Track symptoms weekly: energy, sleep quality, joint pain scores (aim for under 3/10), and weekly morning weights. If weight loss stalls, recalibrate thyroid dosing rather than increasing HRT immediately.

Practical Weight Loss Strategies for Hormonal Challenges

With insurance rarely covering comprehensive programs, my CFP Method focuses on three non-negotiables that fit busy middle-income schedules. First, a 14-hour overnight fast combined with protein-first meals (30g minimum at breakfast) stabilizes blood glucose and reduces Hashimoto's flares. Second, gentle resistance circuits twice weekly using resistance bands or bodyweight moves protect joints while preserving muscle. Third, targeted supplements like 200 mcg selenium, 30 mg zinc, and 1,000 IU vitamin D daily support thyroid conversion and dampen autoimmunity.

Women following this approach typically lose 1.5-2.2 pounds per week after the first month, even with a VUS on file. The method avoids complex meal plans by using simple templates: 40% protein, 30% healthy fat, 30% fiber-rich carbs from vegetables and limited berries. This directly counters the metabolic slowdown caused by low thyroid and perimenopausal estrogen dips.

Monitoring and Next Steps with Your Healthcare Team

Share your VUS report with both your endocrinologist and hormone specialist. Request full thyroid labs every 8 weeks initially, including antibodies. Many patients see antibody levels drop 30-50% within six months when inflammation is controlled through the CFP approach. If your VUS affects the DIO2 gene (common in poor T4-to-T3 converters), prioritize T3-inclusive therapy. Remember, embarrassment about obesity or past diet failures should never delay care; these hormonal shifts are physiological, not personal shortcomings. Start with your primary labs, then book a consult that interprets your VUS in context. Sustainable weight loss becomes achievable when thyroid and sex hormones work together rather than against each other.